Thoracic organ transplantation in the United States, 1995-2004

J B Orens1, T H Shearon, R S Freudenberger

  • 1Johns Hopkins University School of Medicine, Baltimore, MD, USA. jorens@jhmi.edu

Insights

Thoracic organ transplantation trends show declining heart transplant waiting lists and improved survival rates. Lung transplant recipients also experienced decreased waiting times and better survival outcomes.

Area of Science:

  • Cardiology
  • Pulmonology
  • Transplant Surgery

Background:

  • Review of thoracic organ transplantation trends using data from the Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) between 1995 and 2004.
  • Analysis focuses on heart, lung, and combined heart-lung transplantation, examining waiting list dynamics, patient survival, and common indications.

Observation:

  • The number of patients on the heart transplant waiting list decreased, with fewer patients listed for coronary artery disease.
  • Waiting times and waiting list mortality for heart transplants declined significantly.
  • Fewer heart transplants were performed in 2004 compared to 1995, but adjusted 1-year and 5-year patient survival rates improved.

Findings:

  • Emphysema, idiopathic pulmonary fibrosis, and cystic fibrosis were primary indications for lung transplants in 2004.
  • Waiting times for lung transplantation decreased between 1999 and 2004, alongside reduced waiting list mortality.
  • One-year survival rates for lung transplantation showed significant improvement over the decade.

Implications:

  • Improved survival rates suggest advancements in surgical techniques, post-operative care, and donor organ management for heart and lung transplantation.
  • The low number of combined heart-lung transplants performed (39 in 2004) and their poorer survival rates indicate potential challenges or specific indications for this procedure.
  • These trends highlight the evolving landscape of thoracic organ transplantation, emphasizing improved outcomes for single-organ transplants while underscoring areas for further investigation in combined procedures.